The Sunday Roast
The Sunday Roast

Aug 2, 2026 · 1h 45m

Mining deals and biotech catalysts shape a midsummer market review

S11 Ep93: The Sunday Roast, Mid-Summer Special featuring African Pioneer, Poolbeg Pharma, Technology Minerals, Talon Resources and Ajax Resources plc #AFP #POLB #TM1 #TAR #AJAX

The episode tests how financing, clinical evidence, national resilience and exploration milestones could reshape several small-cap stories through 2026.

3 key takeaways
  1. 1African Pioneer outlines a financed route toward Namibian copper production while pursuing a broader regional growth strategy.
  2. 2Poolbeg Pharma links patent protection and clinical data to partnership prospects for POLB-001 in cancer immunotherapy.
  3. 3Technology Minerals, Talon and Ajax present distinct bets on resilience, gold exploration and multi-country resource development.

Don't miss

Colin Bird explains how African Pioneer’s financing and mine-development agreement could advance Namibian copper projects while limiting dilution and management distraction.

The brief

The midsummer special opens with quieter markets, political change and UK fiscal pressure before turning to five companies seeking catalysts ahead of autumn and 2026.

Colin Bird describes African Pioneer’s financed development agreement for Namibian copper projects, arguing that its special-purpose structure can limit dilution while accelerating production.

Poolbeg Pharma’s Jeremy Skillington connects POLB-001’s patent portfolio and Johnson & Johnson trial to the evidence needed for potential pharmaceutical partnerships.

Technology Minerals frames its Mantle strategy around critical-minerals security, advanced manufacturing and UK resilience, drawing on its executives’ defence and logistics experience.

Talon prepares its first Eagle Lake drilling campaign in Ontario with AI-assisted targeting, while Ajax reshapes a multi-country portfolio around drilling, resource studies and 2026 catalysts.

The standout thread is timing: each company presents a different near-term test, from clinical readouts and drilling to mine development and portfolio transactions.

What was said on this episode

49 statements · 42 positive · 4 negative · 1 mixed · 2 neutral

  1. Charles Archeron UK tax risesNegative2:34

    UK tax rises are inevitable under Andy Burnham’s government.

    “the massive tax rises which are inevitably going to come”

    Listen at 2:34

  2. Charles Archeron UK government spending cutsPositive4:36

    Deep UK spending cuts are needed to balance the budget.

    “The solution is spending cuts, really deep, severe spending cuts that balance the budget.”

    Listen at 4:36

  3. Charles Archeron UK AI investmentPositive4:57

    The UK ranks third globally for AI investment and spending.

    “we've got the 3rd highest AI investment and spending in the world”

    Listen at 4:57

  4. African Pioneer is substantially undervalued.

    “African Pioneer is massively undervalued”

    Listen at 6:16

  5. Kevin Hornsbyon Mining investment decisionsPositive7:22

    Investors should act on available information before confirmation to maximize returns.

    “if you want to make the real returns, you got to take the information that you have and, and not wait just for confirmation”

    Listen at 7:22

  6. Charles Archeron Sovereign Metals, Amarok, and GuardianPositive8:03

    Sovereign Metals, Amarok, and Guardian are expected to rise sharply.

    “these things are going to blow”

    Listen at 8:03

  7. African Pioneer’s foundation project could generate $12–15 million annually.

    “can probably generate $12 to $15 million per annum”

    Listen at 11:49

  8. Colin Birdon African Pioneer project developmentNegative13:15

    Developing African Pioneer’s project independently would take six or seven years and £60 million.

    “if you were to do this yourself, I think you're looking at a 6 or 7 year exercise and a lot of money, as we say, about £60 million”

    Listen at 13:15

  9. African Pioneer has consistently been undervalued.

    “it's obviously undervalued and always was”

    Listen at 14:17

  10. African Pioneer could be worth at least three to five times its current valuation.

    “I think you're looking at still, you're still looking at a multiple of 3 or 4 or 5 times where we are now as a minimum”

    Listen at 15:00

  11. Colin Birdon Chinese mining operatorsPositive16:55

    Chinese operators can typically achieve approximately 40% project margins.

    “The Chinese usually could operate at the 40% margin.”

    Listen at 16:55

  12. African Pioneer expects to announce another deal soon.

    “I don't expect a massive, um, a massive interval between, um, this deal being announced and the next deal being announced”

    Listen at 23:22

  13. Colin Birdon KamoaPositive24:43

    Kamoa is the world’s second-largest project.

    “Kamoa is the 2nd biggest project in the world”

    Listen at 24:43

  14. Colin Birdon African Pioneer Botswana projectsNegative27:17

    Botswana is a lower priority than African Pioneer’s Zambian and Namibian projects.

    “Botswana is subordinate to Zambia and absolutely certain to, you know, it's subordinate to what we're doing down in Namibia”

    Listen at 27:17

  15. Jeremy Schepperson Granted pharmaceutical patentsPositive32:46

    Granted patents provide market exclusivity for pharmaceutical programs.

    “what that does then, it kind of allows exclusivity on the market”

    Listen at 32:46

  16. Jeremy Schepperson Poolbeg Pharma POLB-001 patentsPositive33:39

    Poolbeg’s broad POLB-001 patent position is attractive to potential partners.

    “we're kind of first movers here, and having a nice broad patent, I think, is pretty attractive to our potential partners”

    Listen at 33:39

  17. Jeremy Schepperson POLB-001Positive35:23

    Poolbeg aims to enroll approximately 30 patients in its POLB-001 trial.

    “our ultimate goal is to kind of build this up to roughly or approximately 30 patients”

    Listen at 35:23

  18. Jeremy Schepperson POLB-001Positive35:30

    Poolbeg expects trial data to enable partnering of POLB-001.

    “we believe that we'll be able to partner the program because we've started really productive discussions”

    Listen at 35:30

  19. Jeremy Schepperson Cancer immunotherapy-induced cytokine release syndromeNeutral41:56

    Similar mechanisms likely drive cytokine release syndrome across other immunotherapies.

    “our belief is that similar mechanisms drive the CRS with other drugs”

    Listen at 41:56

  20. Jeremy Schepperson Cytokine release syndrome prevention marketPositive43:19

    Preventing cytokine release syndrome represents a multibillion-dollar market.

    “this is a multi-billion dollar space, a multi-billion dollar market”

    Listen at 43:19

  21. Jeremy Schepperson Poolbeg Pharma cash runwayPositive44:37

    Poolbeg’s fundraising provides cash runway through the second quarter of 2028.

    “gives us runway into Q2 of 2028”

    Listen at 44:37

  22. Jeremy Schepperson POLB-001 pharmaceutical partnershipsPositive45:44

    Pharmaceutical companies may pay substantial sums to acquire POLB-001 after positive data.

    “they will, you know, write big checks to bring this in-house”

    Listen at 45:44

  23. Jeremy Schepperson Poolbeg Pharma POLB-001 licensingPositive46:23

    Poolbeg expects significant upfront payments from licensing POLB-001.

    “we will generate significant upfront payments for accessing the program”

    Listen at 46:23

  24. Jeremy Schepperson POLB-001Positive48:47

    Poolbeg expects POLB-001 to reduce or eliminate cytokine release syndrome.

    “we're going to reduce or eliminate CRS”

    Listen at 48:47

  25. Jeremy Schepperson Cytokine release syndrome preventionMixed50:26

    No treatment is currently approved to prevent CRS; Poolbeg hopes to be first.

    “There's no— nothing is approved to prevent CRS right now. We hope to be the first there.”

    Listen at 50:26

  26. Mick Cataldoon Technology MineralsPositive56:51

    Technology Minerals hopes to become cash-flow positive within twelve months.

    “becoming cash flow positive is something we hope to achieve within, within 12 months”

    Listen at 56:51

  27. Mick Cataldoon UK national resiliencePositive58:18

    Technology Minerals aims to improve UK resilience over the next five to thirty years.

    “we're looking at doing is making sure that UK PLC is more resilient to watch what's coming around the corner over the next 5 to 30 years”

    Listen at 58:18

  28. Military procurement should prioritize cheap, accessible, adaptive, rapidly iterative systems.

    “What we need is cheap, accessible, off-the-shelf, highly adaptive, and the ability to iterate really quickly”

    Listen at 1:07:24

  29. Mick Cataldoon Military technology developmentPositive1:08:03

    The military is currently leading technological advances in a rare historical window.

    “we think this is a rare window, like World War II, where for the first time probably since then, the military is actually leading technological advances”

    Listen at 1:08:03

  30. Jeremy Schepperson Talon Resources Eagle LakePositive1:11:54

    Talon’s initial field results increased confidence in Eagle Lake’s discovery potential.

    “Has it increased our confidence? I mean, absolutely.”

    Listen at 1:11:54

  31. Jeremy Schepperson Talon Resources Moss KnollPositive1:13:28

    Talon’s Moss Knoll prospect returned over three metres grading above one gram.

    “we had over 3 meters at over a gram”

    Listen at 1:13:28

  32. Jeremy Schepperson Talon Resources Eagle Lake drillingNeutral1:15:21

    Talon’s initial drill holes will likely reach approximately 150 metres.

    “we're probably going to be somewhere in and around that depth”

    Listen at 1:15:21

  33. Jeremy Schepperson Archean greenstone lode-gold systemsPositive1:16:20

    Archean greenstone lode-gold systems typically improve with depth.

    “typically these kind of greenstone Archean lode gold systems get better with depth”

    Listen at 1:16:20

  34. Jeremy Schepperson Talon Resources Eagle LakePositive1:21:03

    Surface outcrops across Eagle Lake consistently contain gold, often at strong grades.

    “everywhere it does appear at surface, it's got gold in it, and quite often very good levels of gold as well”

    Listen at 1:21:03

  35. Ajax’s strategy is to acquire advanced projects and define their resources.

    “our goal at Ajax is to engage in resource definition”

    Listen at 1:24:16

  36. Ajax may run three concurrent drilling programs.

    “we potentially will have 3 concurrent drill programs”

    Listen at 1:25:34

  37. Ippolito Ingo Cataniaon Ajax Resources Macacha drillingPositive1:25:43

    Ajax expects Macacha drilling could begin in late August.

    “we believe will be imminent. So we have the possibility of starting to drill in August, late August”

    Listen at 1:25:43

  38. Ajax Resources considers its current valuation anomalously low.

    “our valuation is bizarre”

    Listen at 1:27:32

  39. Ajax plans 8,000 metres of drilling across Macacha and Pereira Velo by year-end.

    “we would have started, uh, and hopefully concluded, uh, the 2 drill programs at both Macacha and Pereira Velo, which is a total of 8,000 meters of drilling”

    Listen at 1:29:49

  40. Ajax’s first Pereira Velo resource milestone is 350,000 ounces.

    “our goal there in our, in our transaction structure with Appian, the first, the first milestone is the 350,000 ounces”

    Listen at 1:30:25

  41. Ippolito Ingo Cataniaon Ajax Resources MacachaPositive1:31:09

    Ajax targets ten million tonnes of oxide mineralization at Macacha.

    “a natural target would be the 10 million mark for the oxide”

    Listen at 1:31:09

  42. Ajax expects a significant market-cap re-rating if drilling validates its projects.

    “our market cap, which is currently just below $5 million, uh, will we hope and believe, re-rate very significantly”

    Listen at 1:31:35

  43. Ippolito Ingo Cataniaon Ajax Resources Oslo Euronext listingPositive1:32:43

    Ajax aims to complete an Oslo Euronext listing in September.

    “that IPO is going to be a key goal in September”

    Listen at 1:32:43

  44. Ippolito Ingo Cataniaon Ajax Resources Macacha silver mineralizationPositive1:35:06

    Macacha’s silver mineralization has likely been materially underestimated.

    “the silver mineralization has been highly understated”

    Listen at 1:35:06

  45. Ippolito Ingo Cataniaon Revali Resources EIA permitsPositive1:36:49

    Ajax expects Revali’s EIA permits to be granted.

    “we have good reason to be confident that the EIA permits will be, uh, granted”

    Listen at 1:36:49

  46. Ippolito Ingo Cataniaon Greenfield mineral explorationNegative1:37:58

    Ajax avoids greenfield exploration because it has high risk and low success probability.

    “we intentionally wanted to avoid greenfield exploration because we know how high the risk is and how low the chance of success is”

    Listen at 1:37:58

  47. Ajax’s share price recovery may be faster than its decline.

    “I think hopefully the, the bounce back will be, uh, much quicker than the, the way, the way down”

    Listen at 1:40:12

  48. Ajax’s share price is near its floor because of the company’s cash position.

    “I think this is where the bottom is. I think we're given the cash position, it can't go much lower”

    Listen at 1:40:53

  49. Kevin Hornsbyon Kevin Hornsby Egyptian farmPositive1:44:02

    Kevin’s Egyptian farm aims to feed ten to fifteen families by early next year.

    “our goal is to, uh, to feed, uh, 10 to 15 families, um, from the land within the first 15— sorry, uh, by, by sort of early next year”

    Listen at 1:44:02

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

Mining deals and biotech catalysts shape a midsummer market review | PodLume